AHN, Johns Hopkins Join in Daylong Symposium Oct. 6, Highlighting Biggest Advances, Issues in Breast Cancer Treatment
Friday, September 1, 2017
PITTSBURGH, PA - Allegheny Health Network (AHN) Cancer Institute, in collaboration with Johns Hopkins Kimmel Comprehensive Cancer Institute, will present a day-long “Current Topics in Breast Cancer Symposium,” covering recent advances and controversies related to breast cancer screening, detection and treatment, on Friday, Oct. 6, 2017 at Pittsburgh’s Sheraton Station Square Hotel.
The symposium is open to physicians, nurses, any health care professional in the areas of surgical, medical and radiation oncology, pathology and general surgery, and any practitioner who cares for women.
Conference directors are Thomas B. Julian, MD, FACS, Director of Breast Surgical Oncology, AHN Cancer Institute, and Josh Lauring, MD, PhD and Antonio C. Wolff, MD, FACP, FASCO, both of Johns Hopkins Kimmel Cancer Center. “Participants should find this inaugural symposium, coupled with the keynote address by AHN’s Dr. Norman Wolmark, chair of the NSABP Foundation and chairman and principal investigator of the National Cancer Institute-funded NRG Oncology, to be very educational,” Dr. Julian said.
Topics will include: breast cancer in very young women, and reproductive health considerations; cognitive function in women receiving breast cancer therapy; using tumor gene sequencing for clinical management, emerging treatments for triple-negative breast cancer, and immunotherapy treatment of breast cancer.
Deadline for registration is Sept. 22; after that date reservations will be taken if space is available. To register, visit www.aghcme.org. For more information, contact the AHN Continuing Education office at email@example.com or 412.359.4952.